LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $1,644,574

Key CONT_AWD_75N91026F00023_7529_75N91019D00024_7529. First seen by this system September 4, 2026 through the one time backfill, undated. 2 versions on record; the current one is first below.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91026F00023_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91026F00023_7529_75N91019D00024_7529

Observed 2026-09-04, version 2, retrieved 2026-09-04T16:58:47Z

Content hash 34da94772afd50792d1e5f7e1dc7a965381afd4b5ab7dca0fc56711ad5f3b353

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
2 current	$1,644,574	amount unchanged	August 26, 2026	August 26, 2026	2026-09-04T16:58:47Z	live ingest	`34da94772afd`
1	$1,644,574	first version	not on file	not on file	2026-09-04T12:59:07Z	one time backfill	`f88ad3383da1`

Archived copy

https://web.archive.org/web/20260904173919/https://www.usaspending.gov/award/CONT_AWD_75N91026F00023_7529_75N91019D00024_7529

What the amount is made of

One recorded action, so the amount is that single obligation and nothing about it is cumulative. Measured 2026-09-11, when USAspending reported a total obligation of $1,644,574.

Action date	Modification	Type	Obligated	Description as recorded
August 26, 2026	base	not on file	+$1,644,574	FFRDC DRUG PRODUCT FORMULATION, MANUFACTURE, AND STABILITY STUDIES OF BETHANECHOL CHLORIDE FOR PHASE I CLINICAL TRIALS

Last refreshed November 4, 2026 at 2:31 PM UTC.